Foresite Capital Management IV, LLC Diversified Active

CIK: 0001704132 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 13, 2019

Total Value ($000): $353,792 (100.0% shares, 0.0% debt)

Holdings (22)

— Turning Point Therapeutics, Inc. 21.1%

Value ($000) $74,492 Shares 1,830,265 Est. Cost $40.70 Unrealized —

INSM Insmed Incorporated 11.3%

Value ($000) $39,966 Shares 1,561,185 Est. Cost $26.85 Unrealized +3.8%

ASND Ascendis Pharma A/S 8.0%

Value ($000) $28,261 Shares 245,424 Est. Cost $40.06 Unrealized —

ALEC Alector, Inc. 6.1%

Value ($000) $21,726 Shares 1,143,462 Est. Cost $18.92 Unrealized +7.3%

CYTK Cytokinetics Incorporated 6.0%

Value ($000) $21,363 Shares 1,898,970 Est. Cost $7.56 Unrealized +27.5%

— Biohaven Pharmaceutical Holding Company Ltd. 5.3%

Value ($000) $18,816 Shares 429,690 Est. Cost $26.07 Unrealized —

— CymaBay Therapeutics, Inc. 5.2%

Value ($000) $18,410 Shares 2,571,258 Est. Cost $8.89 Unrealized —

REPL Replimune Group, Inc. 5.1%

Value ($000) $18,012 Shares 1,228,656 Est. Cost $17.53 Unrealized -17.5%

— OptiNose, Inc. 5.0%

Value ($000) $17,857 Shares 2,522,189 Est. Cost $15.00 Unrealized —

— Aerie Pharmaceuticals, Inc. 5.0%

Value ($000) $17,730 Shares 600,000 Est. Cost $31.86 Unrealized —

VYGR Voyager Therapeutics, Inc. 4.1%

Value ($000) $14,611 Shares 536,771 Est. Cost $24.54 Unrealized —

— Myokardia, Inc. 3.6%

Value ($000) $12,909 Shares 257,452 Est. Cost $45.40 Unrealized —

RYTM Rhythm Pharmaceuticals, Inc. 2.9%

Value ($000) $10,329 Shares 469,482 Est. Cost $26.85 Unrealized -6.0%

— The Medicines Company 2.6%

Value ($000) $9,106 Shares 249,672 Est. Cost $36.47 Unrealized —

— NGM Biopharmaceuticals, Inc. 2.0%

Value ($000) $6,899 Shares 471,269 Est. Cost $14.64 Unrealized —

VCYT Veracyte, Inc. 1.6%

Value ($000) $5,702 Shares 200,000 Est. Cost $24.98 Unrealized 0.0%

— Immunomedics, Inc. 1.5%

Value ($000) $5,350 Shares 385,751 Est. Cost $17.13 Unrealized —

SIBN SI-BONE, Inc. 1.2%

Value ($000) $4,182 Shares 205,621 Est. Cost $18.92 Unrealized -9.3%

— Aerie Pharmaceuticals, Inc. 0.8%

Value ($000) $2,970 Shares 100,500 Est. Cost $31.86 Unrealized —

— Aerie Pharmaceuticals, Inc. 0.8%

Value ($000) $2,970 Shares 100,500 Est. Cost $31.86 Unrealized —

ABUS Arbutus Biopharma Corporation 0.4%

Value ($000) $1,265 Shares 608,151 Est. Cost $5.62 Unrealized -54.4%

— Kiniksa Pharmaceuticals, Ltd. 0.2%

Value ($000) $866 Shares 63,922 Est. Cost $17.35 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Turning Point Therapeutics, Inc.	1,830,265	$74,492	21.1%	$40.70	—	COM	90041T108
INSM	Insmed Incorporated	1,561,185	$39,966	11.3%	$26.85	+3.8%	COM	457669307
ASND	Ascendis Pharma A/S	245,424	$28,261	8.0%	$40.06	—	SPONSORED ADR	04351P101
ALEC	Alector, Inc.	1,143,462	$21,726	6.1%	$18.92	+7.3%	COM	014442107
CYTK	Cytokinetics Incorporated	1,898,970	$21,363	6.0%	$7.56	+27.5%	COM NEW	23282W605
—	Biohaven Pharmaceutical Holding Company Ltd.	429,690	$18,816	5.3%	$26.07	—	COM	G11196105
—	CymaBay Therapeutics, Inc.	2,571,258	$18,410	5.2%	$8.89	—	COM	23257D103
REPL	Replimune Group, Inc.	1,228,656	$18,012	5.1%	$17.53	-17.5%	COM	76029N106
—	OptiNose, Inc.	2,522,189	$17,857	5.0%	$15.00	—	COM	68404V100
—	Aerie Pharmaceuticals, Inc.	600,000	$17,730	5.0%	$31.86	—	COM	00771V108
VYGR	Voyager Therapeutics, Inc.	536,771	$14,611	4.1%	$24.54	—	COM	92915B106
—	Myokardia, Inc.	257,452	$12,909	3.6%	$45.40	—	COM	62857M105
RYTM	Rhythm Pharmaceuticals, Inc.	469,482	$10,329	2.9%	$26.85	-6.0%	COM	76243J105
—	The Medicines Company	249,672	$9,106	2.6%	$36.47	—	COM	584688105
—	NGM Biopharmaceuticals, Inc.	471,269	$6,899	2.0%	$14.64	—	COM	62921N105
VCYT	Veracyte, Inc.	200,000	$5,702	1.6%	$24.98	0.0%	COM	92337F107
—	Immunomedics, Inc.	385,751	$5,350	1.5%	$17.13	—	COM	452907108
SIBN	SI-BONE, Inc.	205,621	$4,182	1.2%	$18.92	-9.3%	COM	825704109
—	Aerie Pharmaceuticals, Inc.	100,500	$2,970	0.8%	$31.86	—	Call	00771V108
—	Aerie Pharmaceuticals, Inc.	100,500	$2,970	0.8%	$31.86	—	Put	00771V108
ABUS	Arbutus Biopharma Corporation	608,151	$1,265	0.4%	$5.62	-54.4%	COM	03879J100
—	Kiniksa Pharmaceuticals, Ltd.	63,922	$866	0.2%	$17.35	—	Class A Common	G5269C101